Adage Capital Partners
RLAY icon

Adage Capital Partners’s Relay Therapeutics RLAY Stock Holding History

Adage Capital Partners’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.6M Sell
1,740,000
-850,000
-33% -$12.3M 0.05% 373
2026
Q1 		$25.8M Buy
2,590,000
+2,090,000
+418% +$18.7M 0.04% 406
2025
Q4 		$4.23M Buy
+500,000
New +$3.57M 0.01% 780
2025
Q1 		– Sell
-1,400,000
Closed -$5.77M – 927
2024
Q4 		$5.77M Sell
1,400,000
-250,000
-15% -$1.36M 0.01% 698
2024
Q3 		$11.7M Buy
+1,650,000
New +$12.3M 0.02% 582

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Adage Capital Partners's RLAY Position: Q2 2026 in Review

Adage Capital Partners reduced its Relay Therapeutics (RLAY) stake by 33% in Q2 2026, selling an estimated $12.3M and leaving 1,740,000 shares worth $32.6M. The position accounts for 0.05% of the portfolio, ranked #373.

Adage Capital Partners first reported a position in RLAY in Q3 2024 and has held it in 5 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Adage Capital Partners held 1,740,000 shares of Relay Therapeutics worth $32.6M as of Q2 2026.
  • Adage Capital Partners sold 850,000 Relay Therapeutics shares in Q2 2026, an estimated $12.3M.
  • Relay Therapeutics made up 0.05% of Adage Capital Partners's portfolio in Q2 2026, its #373 holding.
  • Adage Capital Partners first reported a position in Relay Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.